Drug Channels

APRIL 3, 2024

For 2024, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have again each excluded 600 or more drugs from their standard formularies. Click here to see the original post from January 2024. Read on for my deep dive into these two therapeutic categories.

Insulin 52

Insulin Pharmacy Drugs Production 52

XTalks

SEPTEMBER 23, 2020

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. Droplet Micron is now available at local pharmacies.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two

Insulin 96

Insulin Pharmacy Pharma Companies Production 96

The Pharma Data

JULY 29, 2021

Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. Semglee (insulin glargine-yfgn) is the first interchangeable biosimilar product approved in the U.S.

Insulin 52

Insulin Production FDA Approval Generic Drugs 52

The Pharma Data

SEPTEMBER 30, 2021

Lilly’s Insulin Lispro Injection, 100 units/mL — first introduced at half the list price of branded Humalog® (insulin lispro injection, 100 units/mL) in 2019 — will now have a 70 percent lower list price than Humalog U-100 starting January 1, 2022 Insulin Lispro Injection can be ordered through all U.S.

Insulin 52

Insulin Pharmacy Branding Medicine 52

pharmaphorum

APRIL 7, 2022

Last week, a bill to limit the cost of insulin in the US passed the House of Representatives, taking Democrats one step closer to fulfilling their promise of lowering drug costs. The only way you can see to cut back is to cut back on your insulin. Right now, it takes over $2,000 out-of-pocket a month,” she said. Progress or missteps?

Medicine 52

Medicine Insulin Pharmacy Doctors 52

pharmaphorum

JANUARY 28, 2021

Research also shows that embracing biosimilars and patient choice will lead to the competition needed to further increase access to both biosimilars and biologics for 1.2 One of these markets is the insulin market. Up until now, the insulin market has experienced little competition and, as a result, prices have soared over the years.

Marketing 105

Marketing Insulin HR Production 105

Pharmacy Checkers

JULY 25, 2020

The orders call for and include: 1) Lower prices on EpiPens and insulin , 2) Allowing personal drug importation , 3) Ending profit-taking by pharmacy benefit manager middlemen , and 4) “most favored nation” drug price negotiation in Medicare, meaning Medicare would get the lowest price on drugs of any country.

Drugs 73

Drugs Insulin Pharmacy Research 73

XTalks

FEBRUARY 14, 2024

He cited Yale University researcher Dr. Melissa Barber who has estimated that it costs just $18 to manufacture a year’s supply of the drug. Allocation of Profits, PBMs Under Fire The CEOs defended high prescription drug prices saying that a big chunk of pharma profits go towards funding the research and development of new medicines.

Drugs 52

Drugs Insulin Pharmacy Development 52

Pharmaceutical Technology

MARCH 23, 2023

While lifestyle modifications play a key role in treating PCOS, the paucity of new treatments signal a need for breakthrough research. Research states that PCOS is typically characterized by hyperandrogenism, high levels of androgens; ovulatory dysfunction; and polycystic ovaries.

Development 130

Development Insulin Hormones Research 130

Pharmaceutical Technology

DECEMBER 4, 2022

Broadly speaking, price is the determining factor on the US healthcare market, says Jakub Hlávka, PhD, research assistant professor of health policy and management at the University of South California, Los Angeles. For example, the first-to-market status was beneficial when it came to insulin biosimilars.

Marketing 262

Marketing Pharmacy Production Branding 262

pharmaphorum

SEPTEMBER 1, 2020

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. Originating as a pharmacy founded in Darmstadt in 1668, it was in 1827 that Heinrich Emanuel Merck began the transition towards an industrial and scientific concern, by manufacturing and selling alkaloids. Post-war period.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

pharmaphorum

JUNE 10, 2021

The need for firms to make a reasonable profit is paramount in today’s world; healthy pharmaceutical research and manufacturing are the keys to ending disease, curing chronic conditions, and discovering new therapies and vaccines that address the latest medical challenges. Is the Middleman at Fault?

Manufacturing 104

Manufacturing Pharma Companies Drugs Pharmacy 104

Pharmacy Checkers

MARCH 11, 2020

Founded in 2002, and launching its website in 2003, PharmacyChecker provides consumers with online pharmacy verification and comparative drug price information to help them make the best decisions for themselves and their families on how to afford prescription drugs. counterparts.

Pharmacy 41

Pharmacy Drugs FDA Approval Licensing 41

pharmaphorum

APRIL 1, 2022

Semglee (insulin glargine-yfgn) is the first biosimilar available at the retail pharmacy counter, and it obtained interchangeable status. And, manufacturers will likely pay close attention to the impact of Semglee’s interchangeable designation on the adoption of biosimilars in the retail pharmacy space.

Marketing 57

Marketing Pharmacy FDA Approval Manufacturing 57

pharmaphorum

NOVEMBER 4, 2021

Other elements of the plans include tax penalties if pharma companies hike their prices faster than inflation, setting a cap of $35 per month out-of-pocket for insulin, and making sure that Medicare Part D patients don’t pay more than $2,000 per year for medications bought at the pharmacy.

Drugs 52

Drugs Insulin Marketing Medicine 52

pharmaphorum

JANUARY 6, 2023

On 14th November 2022, Eli Lilly apparently wrote on its Twitter account, “We are excited to announce insulin is free now.” As the Russian invasion has continued, some of these trials were able to resume , but the pace of research and development had suffered. Industry frustrations. New drug launches were delayed.

Manufacturing 104

Manufacturing Sales Insulin Drugs 104

The Pharma Data

JANUARY 5, 2021

Besides giving telemedicine a boost, the pandemic has also fostered the rise of innovative medical services, everything from getting prescriptions by mail to drive-through virus testing and pharmacy-based vaccinations. Uscher-Pines was an author on a study that appeared recently in the Journal of Medical Internet Research.

Doctors 52

Doctors Doctor Pharmacy Vaccination 52

XTalks

JANUARY 24, 2024

This disparity can be attributed to various factors, including the lack of government regulation on drug prices and the complex web of negotiations between drug manufacturers, insurers and pharmacy benefit managers.

Drugs 64

Drugs Medicine Insulin Packaging 64

pharmaphorum

JANUARY 24, 2023

Pharma will be focusing more on relevant research, support, and a better mix of non-promotional and promotional interaction. Wholesalers and pharmacies operate under regulations which define storage, supply, and service standards, and these come with energy requirements.

Medicine 98

Medicine Manufacturing Regulation Marketing 98

The Pharma Data

MAY 13, 2021

Description: Ivy League Research Team Shocked As. Breakthrough Research Reveals The One Simple Strategy To Treat All Your Annoying Aches & Pains. The results backed by stacks of scientific research. I Have A Doctorate In Pharmacy, But Everything I Learned About Pain Relief In Pharmacy School Is Dead Wrong!

Pharmacy 52

Pharmacy Production Doctors Doctor 52

XTalks

JUNE 12, 2023

These powerhouse organizations have not only distinguished themselves through their cutting-edge devices and technologies but also via their robust research and development (R&D) capabilities, unwavering commitment to quality and extensive global reach. It also plans to launch these products in the US.

FDA Approval 98

FDA Approval Production Sales In-Vitro 98